20Dec 2017

TNF-a GENE (308G/A) PROMOTER REGION POLYMORPHISM IN METABOLIC SYNDROME: A PILOT STUDY IN NORTH INDIA.

  • Attending Consultant, Biochemistry, Lab Medicine, Jaypee Healthcare, Noida, Uttar Pradesh, India.
  • Associate Professor, Biochemistry, VMMC, New Delhi, India.
  • Professor, Medicine, LHMC & SSKH, New Delhi, India.
  • Director Professor, Biochemistry, LHMC & SSKH, New Delhi, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Metabolic Syndrome is attracting a lot of scientific and commercial interest as the factors defining the syndrome are all associated with increased morbidity and mortality in general and there is still lot of controversy in definitions as well as pathophysiology due to multifactorial etiology. Inflammation and genetic factors play important role along with other factors. Aim: To study the association of TNF-α gene (308G/A) promoter region polymorphism with metabolic syndrome and to study inter genotypic variation of TNF α levels in cases and controls. Materials and Methods: A total of 93 subjects (46 Cases & 47 Controls) were enrolled into the study with informed consent. All subjects were above 25 years of age & cases had metabolic syndrome diagnosed according to IDF 2006 criteria (for Asian population) while controls were age- and sex-matched healthy subjects not fitting into IDF 2006 criteria. TNF-α levels were estimated by Sandwich ELISA and promoter region polymorphism was studied by DNA extraction followed by Polymerase Chain Reaction and Restriction fragment Length Polymorphism. Results: TNF-α level among cases (16.48?6.68 pg/mL) was significantly higher than controls (1.90?0.80 pg/mL). In cases, GG genotype was found in 63 % (29); GA in 33% (15), followed by AA in 4% (2). Among controls GG genotype was present in 85% (40) and GA in 15% (7) and no subject had AA genotype. The genotype distribution was in Hardy Weinberg Equilibrium (χ2 = 6.653, df = 2, p < 0.05). The difference was found statistically significant (p < 0.001). Allelic Frequency difference between the two groups was also significant (p < 0.05). Intergenotypic variations in the levels of TNF-α came significantly different (p<0.05) by ANOVA and T Test Conclusion: We conclude that inflammation is involved in etiopathogenesis of MetS and GA and AA genotype is associated with increased transcription of TNF-α suggesting their regulation at genetic level.

  1. Spinler SA. Challenges associated with metabolic syndrome. Pharmacotherapy 2006 Dec; 26(12, 2): 209S-217S.
  2. Mohan V, Rao GHR. Type 2 Diabetes in South Asains. 1st ed. New Delhi: South Asian Society on Atherosclerosis and Thrombosis; 2007.
  3. Prasad DS, Kabir Z, Dash AK, Das BC. Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: A clinico epidemiological evidence summary. J Cardiovasc Dis Res 2011; 2:199-205.
  4. Misra A, Khurana L. The metabolic syndrome in South Asians: Epidemiology, clinical correlates and possible solutions. International Diabetes Monitor 2009; 21:92-101.
  5. Sonnenberg, G. E., Krakower G.R., Kissebah AH. A novel pathway to the manifestation of metabolic syndrome. Obes Res. 2004 12: 180-186.
  6. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, et al. A Polymorphism in the promoter of the tumour necrosis factor alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 2003 April; 167(2): 257-64.
  7. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor a (TNF-a) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
  8. Aguill?n JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology 2006; 211(1-2): 75?84.
  9. Abraham LJ, Kroeger KM. Impact of the 2308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukocyte Biol 1999; 66: 562-6.
  10. Sookoian S, Garc?a SI, Gianotti TF, Dieuzeide G, Gonz?lez CD, Pirola CJ, et al. The G-308A promoter variant of the tumour necrosis factor-alpha gene is associated with hypertension in adolescents harbouring the metabolic syndrome. Am J Hypertens 2005; 18(10): 1271?5.
  11. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, et al. The TNF-a gene NCO I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. Diabetes 1997; 46: 1468?71.
  12. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. IDF Epidemiology Task Force Consensus Group. Lancet 2005; 366: 1059-1062.
  13. You Tongjian, Alice S. Ryan S. Alice, Nicklas J. Barbara. The Metabolic Syndrome in Obese Postmenopausal Women: Relationship to Body Composition, Visceral Fat, and Inflammation. The Journal of Clinical Endocrinology & Metabolism 2004 November 1; 89 (11): 5517-5522.
  14. Chakraborty S, Zawieja S, Wang W, Zawieja DC, Muthuchamy M. Lymphatic system: A vital link between metabolic syndrome and inflammation. Ann. N.Y. Acad. Sci.2010; S1: E94-E102.
  15. William P. Cawthorn, Jaswinder K. Sethi. TNF-a and adipocyte biology. FEBS Letters 2008; 582: 117?131.
  16. Hotamisligil GS. Inflammation and metabolic disorders.Nature.2006; 444: 860-867.
  17. Elva Perez-Luque, Juan Manuel Malacara, Ma. Eugenia Garay-Sevilla, Martha Eugenia Fajardo. Association of the TNF-α − 308G/A polymorphism with family history of type 2 diabetes mellitus in a Mexican population. Clinical Biochemistry 2012 January; 45(1-2): 12-15.
  18. Abraham LJ, Kroeger KM. Impact of the 308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukocyte Biol 1999; 66: 562-6.
  19. Sookoian SC, Gonz?lez C, Pirola CJ. Meta-analysis on the G-308A tumour necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005; 13(12): 2122?31.
  20. Gupta Vani, Gupta Abhishek, Jafar Tabrez , Gupta Vandana, Agrawal Suraksha, Srivastava Nidhi, et al. Association of TNF-a promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF-a and leptin levels in Indian adult women Cytokine 2012; 57: 32?36.

[Sandhya Lal, Rajni Dawar, M. K. Bhatnagar and Jayashree Bhattacharjee. (2017); TNF-a GENE (308G/A) PROMOTER REGION POLYMORPHISM IN METABOLIC SYNDROME: A PILOT STUDY IN NORTH INDIA. Int. J. of Adv. Res. 5 (Dec). 1099-1105] (ISSN 2320-5407). www.journalijar.com

Dr Sandhya Lal
Lab Medicine (Biochemistry), Jaypee Healthcare, Sector – 128, Noida,India

DOI:

Article DOI: 10.21474/IJAR01/6062      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6062

Download Full Paper

Download PDF No. of Downloads: 3 | No. of Views: 71